Post-transplant lymphoproliferative disorder: Difference between revisions
Jump to navigation
Jump to search
→References: +cat. |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 18: | Line 18: | ||
==IHC== | ==IHC== | ||
*B cell markers +ve. | *B cell markers +ve. | ||
*EBER diffusely +ve. | *[[EBER]] diffusely +ve. | ||
==See also== | ==See also== | ||
| Line 24: | Line 24: | ||
*[[Heart transplant pathology]]. | *[[Heart transplant pathology]]. | ||
*[[Lung transplant pathology]]. | *[[Lung transplant pathology]]. | ||
*[[Lymphoproliferative disorder]]. | |||
==References== | ==References== | ||